| Home Forums |
|
|||||||
| News and Events News related to bone marrow failure diseases |
 |
|
|
Thread Tools | Search this Thread |
|
#1
Sat Feb 17, 2024, 02:04 PM
|
|||
|
|||
|
FDA approves new drug for PNH
__________________
Marlene, wife to John DX w/SAA April 2002, Stable partial remission; Treated with High Dose Cytoxan, Johns Hopkins, June 2002. Final phlebotomy 11/2016. As of July 2021 HGB 12.0, WBC 4.70/ANC 3.85, Plts 110K. 
|
|
#2
Thu Jul 11, 2024, 07:20 PM
|
|||
|
|||
|
The oral drug is iptacopan (trade name Fabhalta). It was found to improve hemoglobin levels and reduce the need for transfusions in adults with PNH.
Iptacopan is a complement factor B inhibitor, which means that it binds to factor B of the alternative complement pathway, preventing hemolysis. In trials it was found to be a better treatment than anti-C5 therapy. Side effects are mostly minor, such as cold symptoms, diarrhea, or rashes, but there's some risk of infections.
__________________
Founder of Marrowforums and caregiver for my wife
|
|
| Thread Tools | Search this Thread |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| FDA Approves Abatacept to Prevent Graft Versus Host Disease | Marrowforums | News and Events | 0 | Fri Feb 11, 2022 11:35 AM |
| FDA warning about OTC diarrhea drug | Marlene | Drugs and Drug Treatments | 5 | Fri Oct 12, 2012 12:57 AM |
| FDA Approves Soliris for PNH Treatment | Marrowforums | News and Events | 2 | Mon Aug 6, 2012 05:23 PM |
| FDA approval for drug for low platelets | Birgitta-A | Drugs and Drug Treatments | 1 | Sat Aug 23, 2008 11:45 AM |
| FDA Approves Intravenous Vidaza for MDS | Marrowforums | News and Events | 2 | Tue Jul 3, 2007 09:41 PM |
